AOTI Inc (AOTI) USD0.00001 (DI)

Sell:85.00pBuy:95.00pNo change

Prices delayed by at least 15 minutes
Sell:85.00p
Buy:95.00p
Change:No change
Prices delayed by at least 15 minutes
Sell:85.00p
Buy:95.00p
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Aoti, Inc. is engaged in wound care technology around the world. The Company is focused on helping all people with chronic conditions get back to living their lives to the fullest. It does this by enhancing access to care, improving clinical outcomes and quality of life, and advancing health equity. Its products are built with integrity and backed by robust clinical evidence, ensuring safety and efficacy for its patients. Its solutions include Topical Wound Oxygen (TWO2) and NEXA Negative Pressure Wound Therapy (NPWT). TWO2 therapy is a multi-modality patient-administered therapy. TWO2 is a clinically proven therapy for the treatment of chronic and difficult-to-heal wounds. The NEXA NPWT System is a multi-week, multi-patient, disposable system that delivers the performance and flexibility of traditional NPWT systems. TWO2 therapy solutions include TWO2 Extremity Chamber and TWO2 Multi-Patch.

Key people

Michael Stephen Griffiths
Chief Executive Officer, Executive Director
Jayesh Pankhania
Chief Financial Officer, Executive Director
Anthony Matthew Moffatt
Chief Operating Officer
Douglas William Frederick Le Fort
Non-Executive Chairman of the Board
Anthony Rhys Bourne
Independent Non-Executive Director
Richard John Cotton
Senior Independent Non-Executive Director
Ceri Elizabeth Morgan
Independent Non-Executive Director
Click to see more

Key facts

  • EPIC
    AOTI
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US03690C1027
  • Market cap
    £95.72m
  • Employees
    80
  • Shares in issue
    106.36m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.